Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial.

Authors :: Galadanci NA
Abdullahi SU
Ali Abubakar S
Wudil Jibir B
Aminu H
Tijjani A
Abba MS
Tabari MA
Galadanci A
Borodo AM
Belonwu R
Salihu AS
Rodeghier M
Ghafuri DL
Covert C Greene BV
Neville K
Kassim AA
Kirkham FJ
Jordan LC
Aliyu MH
DeBaun MR
Source :: American journal of hematology [Am J Hematol] 2020 Sep; Vol. 95 (9), pp. E247-E250. Date of Electronic Publication: 2020 Jul 10.
Publication Year :: 2020

Subjects :: Child
Child, Preschool
Female
Humans
Hydroxyurea adverse effects
Male
Nigeria
Anemia, Sickle Cell drug therapy
Hydroxyurea administration & dosage
Stroke prevention & control

Full Text Access

Tools